Bioequivalence Study of Albendazole 400 mg Tablets in Chinese Population
Clinical trial NCT01755637 · COMPLETED
Trial details
- NCT number
- NCT01755637
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2012-04-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.